||Reason for Update
|Continuous Monitoring of Glucose in the Interstitial Fluid
||References updated. Following statement was added to "When Not Covered" section, The use of intermittently scanned (flash) CGM devices is considered investigational. Medical Director review 1/2022.
|Investigational (Experimental) Services
||COVID-19 related changes extended "effective from March 6, 2020 through June 30, 2022. We will reevaluate if an additional extension is needed as we approach June 30."
||Reference added. Policy Guidelines updated.